Legato Capital Management LLC Eye Point Pharmaceuticals, Inc. Transaction History
Legato Capital Management LLC
- $861 Million
- Q3 2025
A detailed history of Legato Capital Management LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Legato Capital Management LLC holds 37,005 shares of EYPT stock, worth $438,509. This represents 0.06% of its overall portfolio holdings.
Number of Shares
37,005
Previous 37,005
-0.0%
Holding current value
$438,509
Previous $348,000
47.13%
% of portfolio
0.06%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding EYPT
# of Institutions
167Shares Held
68MCall Options Held
421KPut Options Held
401K-
Cormorant Asset Management, LP Boston, MA8.33MShares$98.7 Million18.35% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.19MShares$73.4 Million2.57% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.56MShares$65.9 Million0.13% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.42MShares$52.3 Million0.12% of portfolio
-
Franklin Resources Inc San Mateo, CA4.17MShares$49.4 Million0.02% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $404M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...